Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,598 | 30 | 71.7% |
| Travel and Lodging | $9,313 | 19 | 11.4% |
| Food and Beverage | $5,108 | 128 | 6.3% |
| Consulting Fee | $4,760 | 1 | 5.8% |
| Honoraria | $3,900 | 2 | 4.8% |
| Education | $27.27 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $62,050 | 98 | $0 (2024) |
| ABBVIE INC. | $13,494 | 38 | $0 (2024) |
| Braeburn Inc. | $5,530 | 15 | $0 (2024) |
| ViiV Healthcare Company | $179.95 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $158.22 | 7 | $0 (2024) |
| Smith+Nephew, Inc. | $54.43 | 2 | $0 (2020) |
| Indivior Inc. | $53.30 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.74 | 2 | $0 (2018) |
| Novo Nordisk Inc | $37.46 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $31.68 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,939 | 69 | Gilead Sciences, Inc. ($26,402) |
| 2023 | $47,057 | 84 | Gilead Sciences, Inc. ($35,555) |
| 2022 | $483.35 | 18 | ABBVIE INC. ($334.41) |
| 2021 | $17.75 | 1 | Indivior Inc. ($17.75) |
| 2020 | $89.62 | 3 | AbbVie Inc. ($48.36) |
| 2019 | $81.98 | 4 | Smith+Nephew, Inc. ($33.06) |
| 2018 | $15.84 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15.84) |
| 2017 | $21.90 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21.90) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: VIROLOGY | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.96 | General |
| 11/15/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: HCV | ||||||
| 11/06/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: VIROLOGY | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $1,206.63 | General |
| Category: HCV | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: VIROLOGY | ||||||
| 10/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.82 | General |
| 10/10/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Opioid Use Disorder | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.33 | General |
| 09/27/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: HCV | ||||||
| 08/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $49.72 | General |
| Category: VIROLOGY | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $95.04 | General |
| 08/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $67.29 | General |
| Category: Opioid Use Disorder | ||||||
| 08/15/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Opioid Use Disorder | ||||||
| 08/12/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: HIV | ||||||
| 07/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $41.14 | General |
| Category: VIROLOGY | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.31 | General |
| 06/26/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: HCV | ||||||
| 06/10/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| 05/29/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $728.00 | General |
| Category: HCV | ||||||
| 05/23/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: HCV | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 11 | 11 | $429.00 | $55.40 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 11 | 11 | $429.00 | $55.40 | 12.9% |
About Dr. Matthew Beare, M.D
Dr. Matthew Beare, M.D is a Family Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1326400052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Beare, M.D has received a total of $81,707 in payments from pharmaceutical and medical device companies, with $33,939 received in 2024. These payments were reported across 181 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,598).
As a Medicare-enrolled provider, Beare has provided services to 11 Medicare beneficiaries, totaling 11 services with total Medicare billing of $55.40. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bakersfield, CA
- Active Since 03/22/2016
- Last Updated 01/06/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326400052
Products in Payments
- Epclusa (Drug) $53,169
- MAVYRET (Drug) $10,747
- BRIXADI (Drug) $5,530
- PIFELTRO (Drug) $142.82
- APRETUDE (Biological) $127.21
- Stravix (Biological) $54.43
- SUBLOCADE (Drug) $53.30
- DOVATO (Drug) $52.74
- JARDIANCE (Drug) $37.74
- COBENFY (Drug) $27.27
- Rybelsus (Drug) $22.28
- QULIPTA (Drug) $20.48
- FARXIGA (Drug) $19.89
- AUSTEDO (Drug) $17.81
- Heplisav-B (Drug) $17.21
- BEXSERO (Biological) $16.31
- JANUVIA (Drug) $15.40
- Ozempic (Drug) $15.18
- Austedo XR (Drug) $13.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bakersfield
Mrs. Amira Ayad, M.d, M.D
Family Medicine — Payments: $278,616
Tien Nguyen, M.d, M.D
Family Medicine — Payments: $25,013
Neha Chande, M.d., M.h.s, M.D., M.H.S
Family Medicine — Payments: $20,779
John Heidrick, D.o, D.O
Family Medicine — Payments: $20,029
Dr. Kamrun Naher, M.d, M.D
Family Medicine — Payments: $18,386
Dr. Ashokkumar Ghadia, M.d, M.D
Family Medicine — Payments: $16,231